Compare CLDX & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | ENVX |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 2008 | N/A |
| Metric | CLDX | ENVX |
|---|---|---|
| Price | $25.87 | $7.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $44.10 | $17.14 |
| AVG Volume (30 Days) | 763.6K | ★ 6.1M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,599,000.00 | ★ $30,273,000.00 |
| Revenue This Year | N/A | $36.91 |
| Revenue Next Year | $19.70 | $117.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.98 |
| 52 Week Low | $14.40 | $5.27 |
| 52 Week High | $30.50 | $16.49 |
| Indicator | CLDX | ENVX |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 43.98 |
| Support Level | $24.97 | $7.18 |
| Resistance Level | $28.79 | $9.14 |
| Average True Range (ATR) | 1.36 | 0.58 |
| MACD | -0.36 | 0.00 |
| Stochastic Oscillator | 16.46 | 34.58 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.